Injection Manufacturing
WHO-GMP certified injection manufacturing company in India, producing sterile liquid, dry powder, and ampoule injectables for pharmaceutical brands across therapeutic categories.
| Product Name | Composition | Class | |
|---|---|---|---|
| Brocline Injection | Acetylcysteine 20% w/v Injection ( DPCO ) | Injections | |
| Cefoper - S 1.5gm | Cefoperazone 1000mg+ Sulbactum 500mg Inj. | Injections | Details |
| Cefox - 1.5gm | Cefuroxime 1.5gm Injection. ( DPCO ) | Injections | Details |
| Ceftidel - 1gm | Ceftriaxone 1gm Inj. ( DPCO ) | Injections | |
| Ceftidel - S 1.5gm | Ceftriaxone 1gm+Sulbactum 500mg Inj. ( DPCO ) | Injections | Details |
| Ceftidel - S 375 | Ceftriaxone 250mg+Sulbactum 125mg Inj. | Injections | Details |
| Ceftriaxone and Tazobactam Injection Manufacturer | Ceftriaxone 1000mg + Tazobacatum 125mg Inj. ( DPCO ) | Injections | Details |
| Cidazo | Ceftazidime 250mg+ Tazobactum 31.25mg Inj. | Injections | Details |
| Cinacort Injection | Triamcinolone Acetonide 40 mg Inj. | Injections | |
| Clindel - 300 Inj | Clindamycin 300mg | Dermatology & Cosmetology, Injections | Details |
| Delonate-50 | Nandrolone Deconate 50mg Inj. | Injections | |
| Diclowis-AQ | Diclofenac Sodium 75mg Inj. - AQUA ( DPCO ) | Injections | |
| Doxodet Injection | Doxofylline IP 10mg Injection | Injections | |
| Esodel 40 IV | Esomeprazole Sodium 40mg Injection | Injections | |
| Mecob Plus Injection | Methylcobalamin 1500mcg + Pyridoxine HCl(Vit B6) 100mg + Niacinamide 100mg + D-Panthenol 50mg + Thiamine Hcl 100mg Inj. | Injections | |
| Pentadel I.V. | Pantoprazole 40mg Inj. I.V. ( DPCO ) | Injections | |
| Pipradel - T | Piperacillin 4gm+Tazobactam 500mg Inj. ( DPCO ) | Injections | Details |
| Prednit-40 | Methylprednisolone 40mg Injections ( DPCO ) | Injections | |
| Vomidel Injection | Ondansetron 2mg Inj. ( DPCO ) | Injections |
Comprehensive Sterile Injection Manufacturing
Injectable products carry more regulatory weight than almost any other dosage form — they bypass the body's natural defenses entirely, which is why sterile manufacturing sits under tighter scrutiny than tablets or creams ever will. Delwis Healthcare runs this as a dedicated injection manufacturing company in India, with validated aseptic processing across liquid, dry powder, and ampoule formats.
Brands come to us specifically for that sterile capability — formulation transfer, aseptic scale-up, and commercial production. For portfolios that span more than injectables, the same team also handles tablet, capsule, and cream requirements through CMO manufacturing, but the injectable line runs on its own dedicated, cleanroom-qualified process rather than shared equipment.
Types of Injections We Manufacture
Not every injectable coming off our lines uses the same equipment path. The liquid injections in our current range (Ceftriaxone and Tazobactam, Ceftidel, Pipradel-T) run through vial-fill lines built for liquid injection manufacturing, while ampoule products like Diclowis-AQ and Vomidel go through a fill-seal process built specifically for glass ampoules — the two aren't interchangeable, and treating them as one generic "injection line" is where quality problems usually start.
Dry powder injection manufacturing adds another layer: reconstitution stability becomes the deciding factor in how the formulation is designed, so that gets worked out with a brand before a production run is even scheduled. As a sterile injectable manufacturer in India handling critical care formulations too, we build the extra documentation load those products carry into the project timeline from day one rather than treating it as an add-on.
Injection Manufacturing Process
IV vs. IM Injection & Routes of Administration
Brands formulating a new injectable often need clarity on the difference between IV and IM injection before finalizing a product spec. An IV (intravenous) injection goes directly into a vein, so the medication enters the bloodstream immediately — used where fast onset matters. An IM (intramuscular) injection goes into muscle tissue, where it's absorbed more gradually, which suits medications meant to release over a longer window.
These sit within the broader types of parenteral routes of administration — IV, IM, subcutaneous, and intradermal — each requiring a different formulation viscosity, volume, and packaging format. Getting the route right early shapes everything downstream, from fill volume to container choice.
One distinction worth flagging for brands new to injectables: sterile vs aseptic manufacturing aren't interchangeable terms. "Sterile" describes the end state of the product — free of viable microorganisms. "Aseptic" describes the manufacturing method used to reach that state without a terminal sterilization step. Not every sterile product is made aseptically (some are terminally sterilized after filling), and understanding which method a formulation needs is one of the first technical decisions in project planning.
Sterility Assurance & Cleanroom Controls
Injectable products bypass the body's normal defenses against contamination, which makes sterility failure the single highest-consequence error in pharmaceutical manufacturing — a batch that looks fine visually can still fail a sterility test and be unusable. Our controls are built around catching that risk before release, not after.
- Cleanroom classification maintained and monitored continuously, not just at batch start
- Validated aseptic filling and terminal sterilization systems, selected per product
- Environmental monitoring across every processing zone the product passes through
- In-house sterility and endotoxin testing before any batch is cleared for release
- Full batch documentation and traceability, from WFI generation through final fill
Our Approach
We combine sterile manufacturing expertise with commercial scalability to deliver dependable CMO partnerships. Our model ensures seamless technology transfer, validated scale-up, and predictable third party pharmaceutical manufacturing performance.
Support Services Beyond the Sterile Fill
A compliant, sterile batch is the starting point — getting an injectable product to market takes documentation and testing work that continues well after filling.
Regulatory Documentation for Submission
Dossier-level documentation prepared for domestic approval and export clearance, so a brand isn't building that paperwork from a blank page.
Stability & Sterility Assurance Programs
Ongoing stability studies confirm shelf-life, and sterility assurance testing is run as a standing program, not a one-time release check.
Ampoule & Vial Packaging with Serialization
Fill-finish packaging with full serialization for traceability — a requirement in most export markets for injectable products specifically.
Why Brands Choose Delwis for Injection Manufacturing
Injectable manufacturing carries more regulatory scrutiny than most other dosage forms, so the decision to outsource comes down to trust in infrastructure and documentation as much as price.
Brands We Partner With for Injection Manufacturing
Pharmaceutical companies expanding sterile injectable portfolios
Our Ideal Partners
Global firms seeking third party injection manufacturing in India
Companies needing dry powder or lyophilized injectable capability without building it in-house
Export-focused brands requiring WHO-GMP documentation for regulated markets
Start Your Injection Manufacturing Project
If you are looking for a reliable injection manufacturer in India or injection manufacturer in Baddi for third party pharmaceutical manufacturing, Delwis Healthcare is ready to support your sterile injectable requirements.
No form fields available.
FAQs
Below are common questions from pharmaceutical companies evaluating our CMO and third party pharmaceutical manufacturing capabilities for sterile injections.